554 G. Mugnai et al. prevalence, management, and correlation with prognosis. Heart Rhythm patients with Brugada syndrome and an implantable cardioverter defibrillator to 2014;11:259–65. prevent inappropriate shock therapy. Heart Rhythm 2016;13:1455–9. 3. Pappone C, Radinovic A, Manguso F, Vicedomini G, Sala S, Sacco FM et al. New- 10. Ciconte G, de Asmundis C, Sieira J, Conte G, Di Giovanni G, Mugnai G et al. onset atrial fibrillation as first clinical manifestation of latent Brugada syndrome: Single 3-minute freeze for second-generation cryoballoon ablation: one-year fol- prevalence and clinical significance. Eur Heart J 2009;30:2985–92. low up after pulmonary vein isolation. Heart Rhythm 2015;12:673–80. 4. Kusano KF, Taniyama M, Nakamura K, Miura D, Banba K, Nagase S et al. Atrial 11. Di Giovanni G, Wauters K, Chierchia GB, Sieira J, Levinstein M, Conte G et al. fibrillation in patients with Brugada syndrome relationships of gene mutation, One-year follow-up after single procedure Cryoballoon ablation: a comparison electrophysiology, and clinical backgrounds. J Am Coll Cardiol 2008;51:1169–75. between the first and second generation balloon. J Cardiovasc Electrophysiol 5. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D et al. 2014;25:834–9. Brugada syndrome; report of the second consensus conference: endorsed by the 12. Yap YG, Behr ER, Camm AJ. Drug-induced Brugada syndrome. Europace Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2009;11:989–94. 2005;111:659–70. 13. Morita H, Kusano-Fukushima K, Nagase S, Fujimoto Y, Hisamatsu K, Fujio H et al. 6. Camm AJ, Lip GY, De Caterina R, Savelieva D, Atar D, Hohnloser SH et al; ESC Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome. JAm Committee for Practice Guidelines-CPG. 2012 focused update of the ESC Coll Cardiol 2002;40:1437–44. Guidelines for the management of atrial fibrillation: an update of the 2010 14. Kofune M, Watanabe I, Ohkubo K, Ashino S, Okumura Y, Nagashima K et al. ESC Guidelines for the management of atrial fibrillation – developed with the Abnormal atrial repolarization and depolarization contribute to the inducibility special contribution of the European Heart Rhythm Association. Europace of atrial fibrillation in Brugada syndrome. Int Heart J 2010;51:159–65. 2012;14:1385–413. 15. Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P et al. Genetic 7. Yamada T, Yoshida Y, Tsuboi N, Murakami Y, Okada T, McElderry HT et al. basis and molecular mechanism for idiopathic ventricular fibrillation. Nature Efficacy of pulmonary vein isolation in paroxysmal atrial fibrillation patients with 1998;392:293–6. a Brugada electrocardiogram. Circ J 2008;72:281–6. 16. Calloe K, Cordeiro JM, Di Diego JM, Hansen RS, Grunnet M, Olesen SP et al.A 8. Conte G, Chierchia GB, Wauters K, De Asmundis C, Sarkozy A, Levinstein M transient outward potassium current activator recapitulates the electrocardio- et al. Pulmonary vein isolation in patients with Brugada syndrome and atrial fibril- graphic manifestations of Brugada syndrome. Cardiovasc Res 2009;81:686–94. lation: a 2-year follow-up. Europace 2014;16:528–32. 17. Miyazaki S, Taniguchi H, Kusa S, Komatsu Y, Ichihara N, Takagi T et al. Catheter 9. Kitamura T, Fukamizu S, Kawamura I, Hojo R, Aoyama Y, Komiyama K et al. ablation of atrial tachyarrhythmias causing inappropriate implantable Long-term efficacy of catheter ablation for paroxysmal atrial fibrillation in cardioverter-defibrillator shocks. Europace 2015;17:289–94. Erratum doi:10.1093/europace/euy033 .................................................................................................................................................... Erratum to: Use of leadless pacemakers in Europe: results of the European Heart Rhythm Association survey [Europace 2018;20:555–9]. This paper has been corrected online and in print to add an acknowledgement: ‘This document is supported by Medtronic in the form of an educational grant. The content has not been influenced in any way by its sponsor.’ The Publisher apologises for this error. Published on behalf of the European Society of Cardiology. All rights reserved.V The Author(s) 2018. For permissions, please email: firstname.lastname@example.org. Downloaded from https://academic.oup.com/europace/article-abstract/20/3/554/4862498 by Ed 'DeepDyve' Gillespie user on 16 March 2018
Europace – Oxford University Press
Published: Mar 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera